Relief Therapeutics Holding AG: Revision history

20 August 2022

• curprev 15:2315:23, 20 August 2022 95.149.241.133 talk 1,401 bytes +11 No edit summary undo

13 August 2022

• curprev 23:2123:21, 13 August 2022 109.180.50.163 talk 1,390 bytes +15 No edit summary undo

31 July 2022

• curprev 00:5300:53, 31 July 2022 >Chris 1,375 bytes +1,375 Created page with "Relief Therapeutics Holding AG, a biopharmaceutical company, provides patients with therapeutic relief from serious diseases with high unmet medical need in Switzerland, rest of Europe, North America, and internationally. The company focuses on clinical-stage programs based on molecules with a history of clinical use and either initial human activity or efficacy data or a strong scientific rationale. Its lead compound is RLF-100 (aviptadil), a synthetic human vasoactive..."